(Updated - September 22, 2021 4:13 PM EDT)

Stifel analyst Ben Burnett initiates coverage on Mirati Therapeutics (NASDAQ: MRTX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE